Discovery of 1-Methyl-1 H-imidazole Derivatives as Potent Jak2 Inhibitors

Q Su, S Ioannidis, C Chuaqui, L Almeida…

Index: Journal of Medicinal Chemistry, , vol. 57, # 1 p. 144 - 158

Full Text: HTML

Citation Number: 22

Abstract

... Journal of Medicinal Chemistry. ... event in all patients with MPNs, comprising essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).(5) MF is associated with the lowest survival rate among MPNs and represents a significant unmet medical need.(6 ...

Related Articles:

Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014

[Bioorganic and Medicinal Chemistry Letters, , vol. 23, # 5 p. 1212 - 1216]

Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014

[Bioorganic and Medicinal Chemistry Letters, , vol. 23, # 5 p. 1212 - 1216]

Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014

[Bioorganic and Medicinal Chemistry Letters, , vol. 23, # 5 p. 1212 - 1216]

More Articles...